Laurence Camoin‐Jau

Author

Laurence Camoin‐Jau

Also Known As

Camoin, Laurence, Camoin-Jau, Laurence, Didier Raoult, Frederic Noirot, L CAMOIN‐JAU, L Camoin-Jau, L. CAMOIN‐JAU, L. Camoin-Jau, L. Camoin‐Jau, Laurence CAMOIN-JAU

169

Publications

8.3K

Citations

H-Index

102

Concepts

All Affiliations

Inserm Hôpital de la Timone Aix-Marseille Université Hôpital de la Conception Méditerranée Infection Foundation

About

Laurence Camoin‐Jau is an author at Inserm specializing in medicine, thrombosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	41	3.9K
2	Public Health	7	7	571
3	Health Sciences	3	3	308
4	Biomedical Engineering	2	2	66
5	Engineering	1	1	18

Laurence Camoin‐Jau

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant Valéry Combes, Anne-Christine Simon, Georges E. Grau, Journal of Clinical Investigation	1999	718
Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance Laurent Bonello, Laurence Camoin‐Jau, Stéphane Arquès, Journal of the American College of Cardiology ThrombosisHypertensionClopidogrel ResistanceCardiovascular DiseaseAntihypertensive Therapy	2008	554
Resistance to thienopyridines: Clinical detection of coronary stent thrombosis by monitoring of vasodilator‐stimulated phosphoprotein phosphorylation Paul Barragan, Jean‐Louis Bouvier, Pierre‐Olivier Roquebert, Catheterization and Cardiovascular Interventions	2003	435
Vasodilator‐stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events Laurent Bonello, Franck Paganelli, M. ARPIN‐BORNET, Journal of Thrombosis and Haemostasis Percutaneous Coronary InterventionThrombosisVascular DiseaseCoronary Heart DiseaseCardiovascular Disease	2007	283
Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor–dependent procoagulant activity Florence Sabatier, Veronique Roux, F Anfosso, Blood	2002	280
Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis Laurent Bonello, Laurence Camoin‐Jau, Sebastien Arméro, The American Journal of Cardiology ThrombopoiesisThrombosisPlatelet Reactivity MonitoringSubacute Stent ThrombosisCardiovascular Disease	2008	275
Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome Laurent Bonello, Marc Laine, Nathalie Kipson, Journal of the American College of Cardiology ThrombosisAdenosine Plasma ConcentrationCardiovascular DiseaseMedicineAcute Coronary Syndrome	2013	274
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis Jean‐Christophe Lagier, Matthieu Million, Philippe Gautret, Travel Medicine and Infectious Disease	2020	262
Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome Laurence Camoin‐Jau, Florence Sabatier, D Arnoux, Thrombosis and Haemostasis	2004	221
Effect of Cytochrome P450 Polymorphisms on Platelet Reactivity After Treatment With Clopidogrel in Acute Coronary Syndrome Corinne Frère, Thomas Cuisset, Pierre‐Emmanuel Morange, The American Journal of Cardiology ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletMedicine	2008	209

Page 1